232 related articles for article (PubMed ID: 29917088)
1. Transcatheter valve-in-valve implantation in a degenerated very small Mitroflow prosthesis.
Lopez S; Meyer P; Teboul J; Deharo P; Mihoubi A; Elbeze JP; Lena D; Camarasa P; Laborde JC; Drogoul L
Interact Cardiovasc Thorac Surg; 2018 Dec; 27(6):850-855. PubMed ID: 29917088
[TBL] [Abstract][Full Text] [Related]
2. Balloon-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprostheses: clinical and echocardiographic long-term outcomes.
Mosquera VX; Bouzas-Mosquera A; Vilela-González Y; Velasco C; Salgado-Fernández J; Calviño-Santos R; Vázquez-González N; Vázquez-Rodríguez JM; Herrera-Noreña JM
Interact Cardiovasc Thorac Surg; 2021 Jul; 33(2):173-180. PubMed ID: 33782703
[TBL] [Abstract][Full Text] [Related]
3. Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated small surgical bioprostheses: the Hamburg experience.
Diemert P; Seiffert M; Frerker C; Thielsen T; Kreidel F; Bader R; Schirmer J; Conradi L; Koschyk D; Schnabel R; Reichenspurner H; Blankenberg S; Kuck KH; Treede H; Schaefer U
Catheter Cardiovasc Interv; 2014 Sep; 84(3):486-93. PubMed ID: 24753352
[TBL] [Abstract][Full Text] [Related]
4. Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses.
Van Linden A; Blumenstein J; Möllmann H; Kim WK; Walther T; Kempfert J
Ann Thorac Surg; 2014 Nov; 98(5):1809-13. PubMed ID: 25441789
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
6. Valve-in-valve transcatheter aortic valve implantation overcoming hostile anatomy: Evolut R for the treatment of Mitroflow bioprosthesis dysfunction.
Ruparelia N; Colombo A; Latib A
Cardiovasc Interv Ther; 2016 Oct; 31(4):292-5. PubMed ID: 26371364
[TBL] [Abstract][Full Text] [Related]
7. Severe structural deterioration of small aortic bioprostheses treated with valve-in-valve transcatheter aortic valve implantation.
Stankowski T; Aboul-Hassan SS; Seifi-Zinab F; Herwig V; Kubikova M; Harnath A; Fritzsche D; Perek B
J Card Surg; 2019 Jan; 34(1):7-13. PubMed ID: 30625244
[TBL] [Abstract][Full Text] [Related]
8. Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures.
Pibarot P; Simonato M; Barbanti M; Linke A; Kornowski R; Rudolph T; Spence M; Moat N; Aldea G; Mennuni M; Iadanza A; Amrane H; Gaia D; Kim WK; Napodano M; Baumbach H; Finkelstein A; Kobayashi J; Brecker S; Don C; Cerillo A; Unbehaun A; Attias D; Nejjari M; Jones N; Fiorina C; Tchetche D; Philippart R; Spargias K; Hernandez JM; Latib A; Dvir D
JACC Cardiovasc Interv; 2018 Jan; 11(2):133-141. PubMed ID: 29348008
[TBL] [Abstract][Full Text] [Related]
9. First Lotus aortic valve-in-valve implantation to treat degenerated Mitroflow bioprostheses.
Castriota F; Cavazza C; Secco GG; Micari A; Cremonesi A
EuroIntervention; 2016 Apr; 11(13):1545-8. PubMed ID: 26151953
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter Aortic Valve Implantation for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device (from the Prospective VIVA Post Market Study).
Kornowski R; Chevalier B; Verhoye JP; Holzhey D; Harnath A; Schӓfer U; Teiger E; Manigold T; Modine T; Souteyrand G; Champagnac D; Oh JK; Li S; Tchétché D;
Am J Cardiol; 2021 Apr; 144():118-124. PubMed ID: 33383007
[TBL] [Abstract][Full Text] [Related]
11. Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.
Seiffert M; Conradi L; Baldus S; Knap M; Schirmer J; Franzen O; Koschyk D; Meinertz T; Reichenspurner H; Treede H
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):617-24. PubMed ID: 22169448
[TBL] [Abstract][Full Text] [Related]
12. Sutureless prosthesis for failed small Mitroflow valves: the Perceval-after-Mitroflow procedure.
Chiariello GA; Villa E; Messina A; Dalla Tomba M; Cirillo M; Brunelli F; Mhagna Z; Troise G
Interact Cardiovasc Thorac Surg; 2018 May; 26(5):865-868. PubMed ID: 29340630
[TBL] [Abstract][Full Text] [Related]
13. Valve in valve implantation of the CoreValve Evolut R in degenerated surgical aortic valves.
Schwerg M; Stangl K; Laule M; Stangl V; Dreger H
Cardiol J; 2018; 25(3):301-307. PubMed ID: 29570211
[TBL] [Abstract][Full Text] [Related]
14. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques.
Grubitzsch H; Zobel S; Christ T; Holinski S; Stangl K; Treskatsch S; Falk V; Laule M
Eur J Cardiothorac Surg; 2017 Apr; 51(4):653-659. PubMed ID: 28062549
[TBL] [Abstract][Full Text] [Related]
15. The challenge of valve-in-valve procedures in degenerated Mitroflow bioprostheses and the advantage of using the JenaValve transcatheter heart valve.
Conradi L; Kloth B; Seiffert M; Schirmer J; Koschyk D; Blankenberg S; Reichenspurner H; Diemert P; Treede H
EuroIntervention; 2014 Dec; 10(8):990-4. PubMed ID: 24647151
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses.
Ugur M; Suri RM; Daly RC; Dearani JA; Park SJ; Joyce LD; Burkhart HM; Greason KL; Schaff HV
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1940-6. PubMed ID: 24530199
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction.
Mosquera VX; González-Barbeito M; Bouzas-Mosquera A; Herrera-Noreña JM; Velasco C; Salgado-Fernández J; Calviño-Santos R; Vázquez-González N; Vázquez-Rodríguez JM; Cuenca-Castillo JJ
J Card Surg; 2018 Jul; 33(7):356-362. PubMed ID: 29790206
[TBL] [Abstract][Full Text] [Related]
18. Self-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprosthesis: Early outcomes.
Pascual I; Avanzas P; Hernández-Vaquero D; Díaz R; Del Valle R; Padrón R; Lorca R; León V; Martín M; Alfonso F; Morís C
Int J Cardiol; 2019 Jul; 287():53-58. PubMed ID: 30772015
[TBL] [Abstract][Full Text] [Related]
19. How should I treat a severely symptomatic, high-risk female patient with degenerated mitral (Carpentier-Edwards porcine) and aortic (Sorin Mitroflow) bioprostheses?
Berti S; Cerillo AG; Murzi M; Mariani M; Marchi F; Schäfer U; Attia R; Bapat V; Himbert D; Brochet E; Depoix JP; Nataf P; Vahanian A
EuroIntervention; 2015 Feb; 10(10):1250-2. PubMed ID: 25244311
[No Abstract] [Full Text] [Related]
20. Fate of aortic bioprostheses: An 18-year experience.
Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
